Nomura Holdings
CERE

Nomura Holdings’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Nomura Holdings’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-83,300
Closed -$3.41M – 2085
2024
Q2 		$3.41M Buy
83,300
+33,500
+67% +$1.4M 0.01% 763
2024
Q1 		$2.11M Sell
49,800
-200
-0.4% -$8.4K 0.01% 893
2023
Q4 		$2.12M Buy
+50,000
New +$1.44M 0.01% 937

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Nomura Holdings's CERE Position: Q3 2024 in Review

Nomura Holdings sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 19,209 shares — an estimated $785K sold.

Nomura Holdings first reported a position in CERE in Q4 2023 and held it in 3 quarters. The position peaked at $1.53M in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Nomura Holdings reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Nomura Holdings sold 19,209 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $785K.
  • Nomura Holdings first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • Nomura Holdings's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.53M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Nomura Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.